Salus University is a private university in Elkins Park, Pennsylvania, specializing in degree programs for the health care professions.

During the past decade, Pennsylvania College of Optometry conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pennsylvania College of Optometry" #1 sponsor was "Jaeb Center for Health Research" with 8 trials, followed by "National Eye Institute (NEI)" with 2 trials sponsored, "Eyegate Pharmaceuticals, Inc." with 1 trials sponsored, "Sinclair Technologies, LLC" with 1 trials sponsored and "Stony Brook University" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pennsylvania College of Optometry" #1 collaborator was "National Eye Institute (NEI)" with 9 trials as a collaborator and "Pediatric Eye Disease Investigator Group" with 5 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Pennsylvania College of Optometry" are "Amblyopia" (4 trials), "Convergence Insufficiency" (2 trials), "Intermittent Exotropia" (2 trials), "Myopia" (2 trials) and "Refractive Error" (2 trials). Many other conditions were trialed in "Pennsylvania College of Optometry" in a lesser frequency.

Most popular intervention types in "Pennsylvania College of Optometry" are "Device" (6 trials), "Drug" (3 trials), "Other" (3 trials), "Procedure" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Patching" (2 trials), "Active home-based computer vergence/accommodative therapy" (1 trials), "Atropine" (1 trials), "EGP-437 1.6 mA-min at 0.4 with EyeGate® II System" (1 trials) and "EGP-437 10.0 mA-min at 2.5 mA with EyeGate® II System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pennsylvania College of Optometry" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Pennsylvania College of Optometry". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Pennsylvania College of Optometry, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pennsylvania College of Optometry, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".